Peptides are everywhere—from insulin and GLP-1 medicines to collagen powders and experimental research peptides. This guide explains what peptides are, how they work, what outcomes they can and cannot deliver, and how to think clearly about evidence, safety, and quality.

What Are Peptides?

Peptides are short chains of amino acids that act as messengers in the body, influencing metabolism, growth, repair, appetite, and more. Some peptides are approved medicines (e.g., insulin, GLP-1 receptor agonists), others are dietary proteins (e.g., collagen peptides), and many remain investigational. Mechanism, delivery, and evidence quality determine real-world outcomes.

How Do Peptides Work?

Peptides exert their effects by binding to specific receptors on cell surfaces, triggering downstream signaling cascades. Key mechanisms include:

  • Receptor Agonism: Peptides like GLP-1 agonists bind and activate receptors to stimulate insulin secretion and suppress appetite
  • Enzyme Inhibition: Some peptides block enzymes that would otherwise break down signaling molecules
  • Growth Factor Mimicry: Peptides like IGF-1 analogs mimic growth factors that stimulate tissue repair
  • Neurotransmitter Modulation: Certain peptides influence neurotransmitter release and uptake

Categories of Peptides

Approved Pharmaceutical Peptides

  • Insulin: The original therapeutic peptide, used to manage diabetes for over 100 years
  • GLP-1 agonists: Semaglutide (Ozempic/Wegovy), liraglutide (Victoza/Saxenda) for diabetes and obesity
  • GIP/GLP-1 dual agonists: Tirzepatide (Mounjaro/Zepbound) for diabetes and obesity
  • Growth hormone: Recombinant human GH for specific medical conditions

Investigational/Research Peptides

  • GHRPs: Growth hormone releasing peptides (GHRP-2, GHRP-6, Ipamorelin, Hexarelin)
  • GHRH analogs: CJC-1295, Tesamorelin, Sermorelin
  • Tissue repair peptides: BPC-157, TB-500, GHK-Cu
  • Metabolic peptides: Retatrutide, Mazdutide (in clinical trials)
  • Nootropic peptides: Selank, Semax, Dihexa

Delivery Routes

  • Subcutaneous injection: Most common for research peptides; bypasses first-pass metabolism
  • Intravenous: Faster onset; typically used in clinical settings
  • Intranasal: Some peptides (Selank, Semax) are formulated as nasal sprays
  • Oral: Most peptides are degraded by digestive enzymes; few are orally bioavailable without modification
  • Topical: Some cosmetic peptides (GHK-Cu) are used in skincare formulations

Evaluating Evidence Quality

When assessing peptide research, consider the evidence hierarchy:

  1. Randomized Controlled Trials (RCTs): Highest quality; used for approved drugs
  2. Observational studies: Can show associations but not causation
  3. Animal studies: Provide mechanistic insight but may not translate to humans
  4. In vitro studies: Cell culture results often do not translate to in vivo effects
  5. Anecdotal reports: Lowest quality; subject to placebo effects and reporting bias

Safety Considerations

  • All peptides carry risk of side effects depending on dose, route, and individual factors
  • Purity and sterility of research peptides is critical; contaminated products pose serious risks
  • Interactions with medications and health conditions are possible
  • Long-term safety data is lacking for most investigational peptides

Disclaimer

All information provided is for educational and research purposes only. Investigational peptides are not approved for human therapeutic use. Always consult qualified healthcare professionals for medical guidance.